Counsel Stack
|
Law
Browse
Pricing
Counsel Stack
API Docs
Home
/
CFR
/
Title 21
/
Part 601
FEDERAL · 21 CFR
Part 601 — Licensing
39 sections · Title 21: Food and Drugs
§ 601.2
Applications for biologics licenses; procedures for filing.
§ 601.3
Complete response letter to the applicant.
§ 601.4
Issuance and denial of license.
§ 601.5
Revocation of license.
§ 601.6
Suspension of license.
§ 601.7
Procedure for hearings.
§ 601.8
Publication of revocation.
§ 601.9
Licenses; reissuance.
§ 601.12
Changes to an approved application.
§ 601.14
Regulatory submissions in electronic format.
§ 601.15
Foreign establishments and products: samples for each importation.
§ 601.20
Biologics licenses; issuance and conditions.
§ 601.21
Products under development.
§ 601.22
Products in short supply; initial manufacturing at other than licensed location.
§ 601.27
Pediatric studies.
§ 601.28
Annual reports of postmarketing pediatric studies.
§ 601.29
Guidance documents.
§ 601.30
Scope.
§ 601.31
Definition.
§ 601.32
General factors relevant to safety and effectiveness.
§ 601.33
Indications.
§ 601.34
Evaluation of effectiveness.
§ 601.35
Evaluation of safety.
§ 601.40
Scope.
§ 601.41
Approval based on a surrogate endpoint or on an effect on a clinical endpoint other than survival or irreversible morbidity.
§ 601.42
Approval with restrictions to assure safe use.
§ 601.43
Withdrawal procedures.
§ 601.44
Postmarketing safety reporting.
§ 601.45
Promotional materials.
§ 601.46
Termination of requirements.
§ 601.50
Confidentiality of data and information in an investigational new drug notice for a biological product.
§ 601.51
Confidentiality of data and information in applications for biologics licenses.
§ 601.70
Annual progress reports of postmarketing studies.
§ 601.90
Scope.
§ 601.91
Approval based on evidence of effectiveness from studies in animals.
§ 601.92
Withdrawal procedures.
§ 601.93
Postmarketing safety reporting.
§ 601.94
Promotional materials.
§ 601.95
Termination of requirements.